Acquisition of APIRx

For personal use only APIRX Competitive Advantage The World's largest privately held IP portfolio in cannabinoid- based pharmaceuticals. Incannex Simplified FDA registration strategy to shorten time to commercialization. A robust patent filing strategy and diversified drug portfolio including 22 drug development programs. до Highly credentialed and experienced specialists in medical, academic and scientific team including global key opinion leaders. Track record of corporate value creation for shareholders and significant short term value drivers. Investor Presentation 24

View entire presentation